More than a decade ago, Yale chemist Craig Crews founded a biotechnology company in New Haven based on his pioneering ...

Intermittent fasting has been marketed as a simple health upgrade, the kind of routine you can squeeze between work emails ...

Veppanu represents a scientific milestone as the first-ever proteolysis-targeting chimera (PROTAC) to receive FDA approval.

Total Revenue Increased 30% to $68.4 Million, with MACI Revenue Growth of 22% and Burn Care Revenue Growth of 91% Gross Margin of 72% and ...

Racura Oncology, an Australian Phase 3 stage clinical biopharmaceutical company, reports the discovery of the primary mechanism of action (MOA) of its lead oncology asset, (E,E)-bisantrene. Bisantrene ...

Beauty lovers swear this is the “king” of all vitamin C serums — and it rarely goes on sale.

Looking for the best face wash for oily skin? We tested dozens of formulas to find the best cleansers for oil control, ...

Your forehead is part of your T-zone, which produces more oil than other facial areas, making it prone to acne. It has high ...

Immunotherapy has become a standard of care in treating high-risk, early-stage breast cancers, yet it has had limited success ...

Trendy *and* hardworking — now that's what I'm talking about.

The best face washes for oily, spot-prone skin, tested. These cleansers for men will banish grease, to leave skin clearer and ...

Arvinas, Inc. (Nasdaq: ARVN), a biotechnology company working to create a new class of drugs based on targeted protein degradation, today announced that management will review first quarter 2026 ...